Search Results

QT Alterations in Psychopharmacology: Proven Candidates and Suspects

Authors: Alvarez, Paulino A.; Pahissa, Jaime

Source: Current Drug Safety, Volume 5, Number 1, January 2010 , pp. 97-104(8)

Publisher: Bentham Science Publishers

The prefrontal cortex: a target for antipsychotic drugs

Author: Artigas, F.

Source: Acta Psychiatrica Scandinavica, Volume 121, Number 1, January 2010 , pp. 11-21(11)

Publisher: Blackwell Publishing

Mechanisms of Action of Antipsychotic Drugs of Different Classes, Refractoriness to Therapeutic Effects of Classical Neuroleptics, and Individual Variation in Sensitivity to their Actions: PART I

Author: Miller, R.

Source: Current Neuropharmacology, Volume 7, Number 4, December 2009 , pp. 302-314(13)

Publisher: Bentham Science Publishers

Mechanisms of Action of Antipsychotic Drugs of Different Classes, Refractoriness to Therapeutic Effects of Classical Neuroleptics, and Individual Variation in Sensitivity to their Actions: PART II

Author: Miller, R.

Source: Current Neuropharmacology, Volume 7, Number 4, December 2009 , pp. 315-330(16)

Publisher: Bentham Science Publishers

Can the Sigma-1 Receptor Agonist Fluvoxamine Prevent Schizophrenia?

Author: Hashimoto, Kenji

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 8, Number 6, December 2009 , pp. 470-474(5)

Publisher: Bentham Science Publishers

Sudden death in patients receiving drugs tending to prolong the QT interval

Authors: Jolly, Kate; Gammage, Michael D.; Cheng, Kar Keung; Bradburn, Peter; Banting, Miriam V.; Langman, Michael J. S.

Source: British Journal of Clinical Pharmacology, Volume 68, Number 5, November 2009 , pp. 743-751(9)

Publisher: Blackwell Publishing

Early effects of mood stabilizers on the Akt/GSK-3β signaling pathway and on cell survival and proliferation

Authors: Aubry, Jean-Michel; Schwald, Michèle; Ballmann, Eladia; Karege, Félicien

Source: Psychopharmacology, Volume 205, Number 3, August 2009 , pp. 419-429(11)

Publisher: Springer

Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study

Authors: Pouwels, S.; Staa, T.; Egberts, A.; Leufkens, H.; Cooper, C.; Vries, F.

Source: Osteoporosis International, Volume 20, Number 9, September 2009 , pp. 1499-1506(8)

Publisher: Springer

Aggressive Behaviour in Adults with Intellectual Disability: Defining the Role of Drug Treatment

Authors: Oliver-Africano, Patricia; Murphy, Declan; Tyrer, Peter

Source: CNS Drugs, Volume 23, Number 11, 1 November 2009 , pp. 903-913(11)

Publisher: Adis International

Effectiveness of Safety Warnings in Atypical Antipsychotic Drugs: An Interrupted Time-Series Analysis in Spain

Authors: Sanfélix-Gimeno, Gabriel; Cervera-Casino, Pedro; Peiró, Salvador; López-Valcarcel, Beatriz González; Blázquez, Amparo; Barbera, Teresa

Source: Drug Safety, Volume 32, Number 11, 1 November 2009 , pp. 1075-1087(13)

Publisher: Adis International

Antipsychotic Drugs for First-Episode Schizophrenia: A Comparative Review

Authors: Salimi, Kayvon; Jarskog, L. Fredrik; Lieberman, Jeffrey A.

Source: CNS Drugs, Volume 23, Number 10, 1 October 2009 , pp. 837-855(19)

Publisher: Adis International

What do ERPs and ERFs Reveal About the Effect of Antipsychotic Treatment on Cognition in Schizophrenia?

Authors: Korostenskaja, M.; Kahkonen, S.

Source: Current Pharmaceutical Design, Volume 15, Number 22, August 2009 , pp. 2573-2593(21)

Publisher: Bentham Science Publishers

The CATIE and CUtLASS Studies in Schizophrenia: Results and Implications for Clinicians

Authors: Naber, Dieter; Lambert, Martin

Source: CNS Drugs, Volume 23, Number 8, 8 August 2009 , pp. 649-659(11)

Publisher: Adis International

Cost analysis in a Medicaid program for patients with bipolar disorder who initiated atypical antipsychotic monotherapy*

Authors: Qiu, Ying; Christensen, Dale B.; Fu, Alex Z.; Liu, Gordon G.

Source: Current Medical Research and Opinion, Volume 25, Number 2, February 2009 , pp. 351-361(11)

Publisher: Informa Healthcare

Depression-like behavior in the forced swimming test in PACAP-deficient mice: amelioration by the atypical antipsychotic risperidone

Authors: Hashimoto, Hitoshi; Hashimoto, Ryota; Shintani, Norihito; Tanaka, Kazuhiro; Yamamoto, Akiko; Hatanaka, Michiyoshi; Guo, Xiaohong; Morita, Yoshiko; Tanida, Mamoru; Nagai, Katsuya; Takeda, Masatoshi; Baba, Akemichi

Source: Journal of Neurochemistry, Volume 110, Number 2, July 2009 , pp. 595-602(8)

Publisher: Blackwell Publishing

Impact of Patient Selection Criteria and Treatment History on Comparisons of Alternative Therapies: A Case Study of Atypical Antipsychotics

Authors: Marshall, Thomas S.; McCombs, Jeffery S.; Stafkey-Mailey, Dana

Source: Value in Health, Volume 12, Number 4, June 2009 , pp. 473-480(8)

Publisher: Blackwell Publishing

Neuroleptic Malignant Syndrome Associated with Atypical Antipsychotic Drugs

Authors: Trollor, Julian N.; Chen, Xiaohua; Sachdev, Perminder S.

Source: CNS Drugs, Volume 23, Number 6, 30 May 2009 , pp. 477-492(16)

Publisher: Adis International

Atypical Antipsychotic Drugs During Pregnancy. Their Effects on the Mother and Offspring

Authors: Iveli, Maria F.; Rebolledo, Alejandro; Milesi, Veronica

Source: Current Women's Health Reviews, Volume 5, Number 2, May 2009 , pp. 100-108(9)

Publisher: Bentham Science Publishers

Utility of Atypical Antipsychotics in the Treatment of Resistant Unipolar Depression

Authors: DeBattista, Charles; Hawkins, Jessica

Source: CNS Drugs, Volume 23, Number 5, 19 May 2009 , pp. 369-377(9)

Publisher: Adis International

Time-Lapse Mapping of Cortical Changes in Schizophrenia with Different Treatments

Authors: Thompson, Paul M.; Bartzokis, George; Hayashi, Kiralee M.; Klunder, Andrea D.; Lu, Po H.; Edwards, Nancy; Hong, Michael S.; Yu, Michael; Geaga, Jennifer A.; Toga, Arthur W.; Charles, Cecil; Perkins, Diana O.; McEvoy, Joseph; Hamer, Robert M.; Tohen, Mauricio; Tollefson, Gary D.; Lieberman, Jeffrey A.

Source: Cerebral Cortex, Volume 19, Number 5, 20 May 2009 , pp. 1107-1123(17)

Publisher: Oxford University Press